These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2476626

  • 1. Indecainide: effects on arrhythmias, electrophysiology, and cardiovascular dynamics.
    Holland DR, Lacefield WB, Gonzales CR, Johnston SR, Turk JA.
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):454-61. PubMed ID: 2476626
    [Abstract] [Full Text] [Related]

  • 2. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    Brown BS, Calzadilla SV, Diemer MJ, Hartman JC, Reynolds RD.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
    [Abstract] [Full Text] [Related]

  • 3. The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251).
    Torchiana ML, Stone CA, Wenger HC, Evans R, Lagerquist B, O'Malley T.
    J Pharmacol Exp Ther; 1975 Aug; 194(2):415-26. PubMed ID: 1151767
    [Abstract] [Full Text] [Related]

  • 4. N-(2,6-Dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent.
    Aisaka K, Hidaka T, Inomata N, Hamasaki S, Ishihara T, Morita M.
    Arzneimittelforschung; 1985 Aug; 35(8):1239-45. PubMed ID: 4074441
    [Abstract] [Full Text] [Related]

  • 5. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
    Bergey JL, Sulkowski T, Much DR, Wendt RL.
    Arzneimittelforschung; 1983 Aug; 33(9):1258-68. PubMed ID: 6685506
    [Abstract] [Full Text] [Related]

  • 6. Contrastive effects of prostaglandin F2 alpha on normal cardiac rhythm and ouabain-induced cardiac arrhythmias in cats: possible neural basis.
    Rao TS, Seth SD, Manchanda SC, Nayar U.
    Arch Int Pharmacodyn Ther; 1989 Aug; 302():128-44. PubMed ID: 2636814
    [Abstract] [Full Text] [Related]

  • 7. Effects on rabbit cardiac potentials of aprindine and indecainide, a new antiarrhythmic agent, in normoxia and hypoxia.
    Dennis PD, Vaughan Williams EM.
    Br J Pharmacol; 1985 May; 85(1):11-9. PubMed ID: 4027460
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107.
    Varró A, Rabloczky G, Jaszlits L, Kürthy M, Zubovics Z, Toldy L.
    Drugs Exp Clin Res; 1987 May; 13(1):21-8. PubMed ID: 3595441
    [Abstract] [Full Text] [Related]

  • 9. Effect of glucagon on arrhythmias induced by coronary artery occlusion and ouabain in dogs.
    Singh J, Bala S, Kaur AH, Garg KN.
    Indian J Physiol Pharmacol; 1980 May; 24(4):329-34. PubMed ID: 7216388
    [Abstract] [Full Text] [Related]

  • 10. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A, Gout B, Bonhomme M, Landais L, Faivre JF, Linee P, Poyser RH, Ruffolo RR.
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [Abstract] [Full Text] [Related]

  • 11. 1-[4-(2-ter-butyl-quinolyl)]-3-(4-piperidyl)propanol (PK 10139): a new potent and long-acting antiarrhythmic agent.
    Mestre M, Bouetard G, Le Fur G, Renault C, Gueremy C, Uzan A.
    J Pharmacol Exp Ther; 1983 Apr; 225(1):158-63. PubMed ID: 6834268
    [Abstract] [Full Text] [Related]

  • 12. Indecainide compared with quinidine for chronic stable ventricular arrhythmias secondary to coronary artery disease or to cardiomyopathy.
    Giardina EG, Zaim S, Saroff AL, Kirschenbaum M.
    Am J Cardiol; 1987 Sep 01; 60(7):584-9. PubMed ID: 2442993
    [Abstract] [Full Text] [Related]

  • 13. Antiarrhythmic and antifibrillatory properties of aprindine.
    Kroll DA, Lucchesi BR.
    J Pharmacol Exp Ther; 1975 Aug 01; 194(2):427-34. PubMed ID: 1151768
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
    Lynch JJ, Wallace AA, Stupienski RF, Baskin EP, Beare CM, Appleby SD, Salata JJ, Jurkiewicz NK, Sanguinetti MC, Stein RB.
    J Pharmacol Exp Ther; 1994 May 01; 269(2):541-54. PubMed ID: 7802864
    [Abstract] [Full Text] [Related]

  • 16. Indecainide for treatment of ventricular ectopic depolarizations: efficacy, pharmacokinetics, hemodynamic effects and safety.
    Salerno DM, Krejci J, Granrud G, Hodges M.
    J Am Coll Cardiol; 1988 Apr 01; 11(4):843-50. PubMed ID: 3351153
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antiarrhythmic effects of oral indecainide in patients with ventricular tachyarrhythmias.
    Macina G, Turitto G, Stavens C, Fontaine J, Hariman R, Ursell S, el-Sherif N.
    Clin Cardiol; 1987 Jun 01; 10(6):357-61. PubMed ID: 3594958
    [Abstract] [Full Text] [Related]

  • 19. Electrophysiologic, antiarrhythmic and cardiovascular actions of UM301, a quaternary ammonium compound.
    Gibson JK, Patterson E, Lucchesi BR.
    J Pharmacol Exp Ther; 1986 Apr 01; 237(1):318-25. PubMed ID: 3754279
    [Abstract] [Full Text] [Related]

  • 20. Influence of pretreatment with phenytoin, lidocaine and quinidine on the cardiodynamic and electrophysiological effects of ouabain in the cat heart-lung preparation.
    Simaan JA.
    Arch Int Pharmacodyn Ther; 1993 Apr 01; 324():47-59. PubMed ID: 8297185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.